Next Article in Journal
"Pharmakognosie – Phytopharmazie"
Previous Article in Journal
Cyclosporine A-Nanosuspension: Formulation, Characterization and In Vivo Comparison with a Marketed Formulation
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Preparation and In Vitro/In Vivo Characterization of Porous Sublingual Tablets Containing Ternary Kneaded Solid System of Vinpocetine with β-Cyclodextrin and Hydroxy Acid

by
Mona H. ABURAHMA
*,
Hanan M. EL-LAITHY
and
Yassin El-Said HAMZA
Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2010, 78(2), 363-380; https://doi.org/10.3797/scipharm.0912-04
Submission received: 3 December 2009 / Accepted: 16 May 2010 / Published: 17 May 2010

Abstract

The demand for sublingual tablets has been growing during the previous decades especially for drugs with extensive hepatic first-pass metabolism. Vinpocetine, a widely used neurotropic agent, has low oral bioavailability due to its poor aqueous solubility and marked first-pass metabolism. Accordingly, the aim of this work was to develop tablets for the sublingual delivery of vinpocetine. Initially, the feasibility of improving vinpocetine’s poor aqueous solubility by preparing kneaded solid systems of the drug with β-Cyclodextrin and hydroxy acids (citric acid and tartaric acid) was assessed. The solid system with improved solubility and dissolution properties was incorporated into porous tablets that rapidly disintegrate permitting fast release of vinpocetine into the sublingual cavity. The pores were induced into these tablets by directly compressing the tablets’ excipients with a sublimable material, either camphor or menthol, which was eventually sublimated leaving pores. The obtained results demonstrated that the tablets prepared using camphor attained sufficient mechanical strength for practical use together with rapid disintegration and dissolution. In vivo absorption study performed in rabbits indicated that the sublingual administration of the proposed porous tablets containing vinpocetine solid system with β-Cyclodextrin and tartaric acid could be useful for therapeutic application.
Keywords: Hydroxy acids; Sublimable materials; Sublingual Porous tablets; Vinpocetine; β-Cyclodextrin Hydroxy acids; Sublimable materials; Sublingual Porous tablets; Vinpocetine; β-Cyclodextrin

Share and Cite

MDPI and ACS Style

ABURAHMA, M.H.; EL-LAITHY, H.M.; HAMZA, Y.E.-S. Preparation and In Vitro/In Vivo Characterization of Porous Sublingual Tablets Containing Ternary Kneaded Solid System of Vinpocetine with β-Cyclodextrin and Hydroxy Acid. Sci. Pharm. 2010, 78, 363-380. https://doi.org/10.3797/scipharm.0912-04

AMA Style

ABURAHMA MH, EL-LAITHY HM, HAMZA YE-S. Preparation and In Vitro/In Vivo Characterization of Porous Sublingual Tablets Containing Ternary Kneaded Solid System of Vinpocetine with β-Cyclodextrin and Hydroxy Acid. Scientia Pharmaceutica. 2010; 78(2):363-380. https://doi.org/10.3797/scipharm.0912-04

Chicago/Turabian Style

ABURAHMA, Mona H., Hanan M. EL-LAITHY, and Yassin El-Said HAMZA. 2010. "Preparation and In Vitro/In Vivo Characterization of Porous Sublingual Tablets Containing Ternary Kneaded Solid System of Vinpocetine with β-Cyclodextrin and Hydroxy Acid" Scientia Pharmaceutica 78, no. 2: 363-380. https://doi.org/10.3797/scipharm.0912-04

APA Style

ABURAHMA, M. H., EL-LAITHY, H. M., & HAMZA, Y. E. -S. (2010). Preparation and In Vitro/In Vivo Characterization of Porous Sublingual Tablets Containing Ternary Kneaded Solid System of Vinpocetine with β-Cyclodextrin and Hydroxy Acid. Scientia Pharmaceutica, 78(2), 363-380. https://doi.org/10.3797/scipharm.0912-04

Article Metrics

Back to TopTop